Chemically Diverse S. mansoni HDAC8 Inhibitors Reduce Viability in Worm Larval and Adult Stages
ChemMedChem · 2023-02 · 18 (3)
DOI: 10.1002/cmdc.202200510 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 08.11.2022. Verfasst von Beatrice Noce und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Chemistry and Technologies, Sapienza University of Rome, 00185, Rome, Italy. Hauptthemen laut MEDLINE: Histone Deacetylase Inhibitors, Histone Deacetylases, Schistosoma mansoni, Schistosomiasis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.
Abstract (Originalsprache)
Schistosoma mansoni HDAC8 is a reliable target to fight schistosomiasis, and several inhibitors have been reported in the literature up to now. Nevertheless, only a few displayed selectivity over the human deacetylases and some exhibited very low or no activity against parasite larvae and/or adult worms. We report here the in vitro enzyme and biological activity of a small library of HDAC inhibitors from our lab, in many cases exhibiting submicromolar/nanomolar potency against smHDAC8 and diverse degrees of selectivity over hHDAC1 and/or hHDAC6. Such compounds were tested against schistosomula, and a selection of them against the adult forms of S. mansoni , to detect their effect on viability. Some of them showed the highest viability reduction for the larval stage with IC 50 values around 1 μM and/or displayed ∼40–50 % activity in adult worms at 10 μM, joined to moderate to no toxicity in human fibroblast MRC‐5 cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Drug Chemistry and Technologies, Sapienza University of Rome, 00185, Rome, Italy.
- Research Laboratories, Bambino Gesù Children's Hospital-IRCCS, 00146, Rome, Italy.
- Institute of Molecular Biology and Pathology, National Research Council (CNR), 00185, Rome, Italy.
- Institute of Pharmaceutical Sciences, Albert-Ludwigs-Universität Freiburg, 79104, Freiburg, Germany.
- Département de Biologie Structurale Intégrative, Institut de Génétique et Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, CNRS, INSERM, 67404, Illkirch Cedex, France.
- Institute of Pharmacy, Martin Luther University of Halle-Wittenberg, 06120, Halle (Saale), Germany.
ORCID-Profile: Antonello Mai
Förderung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Zitieren
APA
Noce, B., Di Bello, E., Zwergel, C., Fioravanti, R., Valente, S., Rotili, D., Masotti, A., Salik Zeya Ansari, M., Trisciuoglio, D., Chakrabarti, A., Romier, C., Robaa, D., Sippl, W., Jung, M., Häberli, C., Keiser, J., & Mai, A. (2023). Chemically Diverse S. mansoni HDAC8 Inhibitors Reduce Viability in Worm Larval and Adult Stages. ChemMedChem, 18(3). https://doi.org/10.1002/cmdc.202200510
Vancouver
Noce B, Di Bello E, Zwergel C, Fioravanti R, Valente S, Rotili D, et al. Chemically Diverse S. mansoni HDAC8 Inhibitors Reduce Viability in Worm Larval and Adult Stages. ChemMedChem. 2023;18(3). doi:10.1002/cmdc.202200510
BibTeX
@article{Noce2023,
author = {Noce, Beatrice and Di Bello, Elisabetta and Zwergel, Clemens and Fioravanti, Rossella and Valente, Sergio and Rotili, Dante and Masotti, Andrea and Salik Zeya Ansari, Mohammad and Trisciuoglio, Daniela and Chakrabarti, Alokta and Romier, Christophe and Robaa, Dina and Sippl, Wolfgang and Jung, Manfred and Häberli, Cécile and Keiser, Jennifer and Mai, Antonello},
title = {Chemically Diverse S. mansoni HDAC8 Inhibitors Reduce Viability in Worm Larval and Adult Stages},
journal = {ChemMedChem},
year = {2023},
volume = {18},
number = {3},
doi = {10.1002/cmdc.202200510}
}
EUVIMED